July 11th, 2025: Ozempic Vision Loss Lawsuit Filed After 85% Eye Damage Alleged from NAION On July 10, 2025, a new lawsuit was filed in the Southern District of New York alleging that Ozempic caused 85% vision loss in one eye due to non-arteritic anterior ischemic optic neuropathy (NAION)
It is one of the most important molecules for liver detoxification and protects against damage caused by alcohol, medication, or toxins
At MedHealth 360, we specialize in personalized weight loss treatments, including semaglutide injections, tailored to your unique needs
But there is another important possibility offered by these medications their potential as disease-modifying treatments for Parkinsons disease
Mounjaro (tirzepatide): MHRA approval November 2023, NICE TA1026 issued December 2024
Many patients see success when combining GLP-1 injections with healthy lifestyle habits